No Data
No Data
No Data
No Data
No Data
Sinovac Biotech Embraces Post-Pandemic Challenges
TipRanksApr 30 07:29 ET
Sinovac Biotech 2H Sales $307.9 >SVA
Sinovac Biotech 2H Sales $307.9 >SVA
Dow JonesApr 29 17:54 ET
Seasonal Influenza Global Clinical Trials Review 2024 Featuring GSK, Novartis, Johnson & Johnson, Novavax, CSL, Sinovac Biotech, Moderna, and Sanofi, Among Others
Yahoo FinanceApr 5 09:29 ET
Sinovac: Given Ongoing Litigation Concerning Exchange of Shares & Rights Agreement, Unclear If or When Halt Will Lift >SVA
Sinovac: Given Ongoing Litigation Concerning Exchange of Shares & Rights Agreement, Unclear If or When Halt Will Lift >SVA
Dow JonesSep 5, 2023 04:33 ET
Sinovac Is a China-based Biopharma Co With Vaccine Portfolio Including Covid, Hep A >SVA
Sinovac Is a China-based Biopharma Co With Vaccine Portfolio Including Covid, Hep A >SVA
Dow JonesSep 5, 2023 04:33 ET
Sinovac: These Inlcude That Trading of Company's Shares on Nasdaq Has Been Halted Since February 2019 >SVA
Sinovac: These Inlcude That Trading of Company's Shares on Nasdaq Has Been Halted Since February 2019 >SVA
Dow JonesSep 5, 2023 04:29 ET
krithoonsuwan : This is the same situation as before Moderna was commercially used.
Dantan6 : Xiao char bo spreading speculation and rumors
YC Xiao : let's hear from scientists and doctors
Raeann Loebs : I don't advocate to buy 1099 because it has many products thus revenue from vaccine sale could be diluted by others. This is somewhat like PFE. If you compare PFE vs BNTX, then you can find BNTX jumped far more than PFE.
wild horse : Perhaps 1099 should have created a separated company to make and sell vaccine but that didn't happen. It smanagement should go to Wall Street to learn more.
Brandon Golden : spewing more of your classic misinformation drivel we see
Geminiasianboi : What about product fatigue. Lots of people losing faith in MRNA after watching countries with high % vaccination with breakthrough cases? Israel and Germany come to mind. Novavax is a great alternative coming to market. ESP anti-MRNA ppl will get jabs in droves IMHO. Under developed countries with warmer climate will also prefer novavax.
IT farmer Geminiasianboi:
NVAX needs to prove this but where are grounds? Nations use vaccines which they know.
NVAX has a bigger issue of its poor results in S. Africa.
Roleodo IT farmer: Pfizer claims their vaccine is 75% effective against B1351, theirs was based on trial in Qatar where two variants (B1351 & B117) were spreading there. Moderna did not do a trial to test the efficacy yet, but as a booster shot study shows increased antibodies against B1351. Novavax 60% efficiency was based on trial in SA where B1351 is the predominant variant. Pfizer and Moderna study is not apple to apple with Novavax we should not make premature conclusion on the superiority of Pfizer/Moderna vaccine against B1351.
QianmengYu : Merck‘s pill is more dangerous. It gets into RNA copy process and write wrong NA into the chain. However it could also write into human RNA chain. Also the NA could also be reused for copying human DNA, which could cause cancer or even mutation. Very dangerous and current trial only see hundreds of people in short period
CWL8 : Good
No Data
No Data